NCT02306629: Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood |
|
|
| Completed | 1 | 42 | Europe | Epratuzumab sc, Epratuzumab iv, CDP3194, EMAB | UCB Biopharma S.P.R.L., Pharmaceutical Research Associates, Richmond Pharmacology Limited, ACM Global Laboratories, Eurofins, The Doctors Laboratory | Systemic Lupus Erythematosus | 04/15 | 04/15 | | |
